PD TALKS |
|
PD TALKS |
|
Dr. Ihtsham Haq graduated from Columbia University with degrees in Bioengineering and in Philosophy. He completed his Neurology residency training at Georgetown University and his fellowship training at the University of Florida’s Movement Disorders & Neuro-restoration program at the Norman Fixel Institute for Neurological Diseases. He was previously Associate Professor at the Wake Forest School of Medicine in the Departments of Neurology and Neurosurgery before taking his current position as Division Chief at Miami in 2020.
His overall research interest has been in understanding and improving the care of patients with movement disorders, with a focus on technology and brain circuitry. He has been funded by the National Institute of Health, Parkinson’s Foundation, and Smallwood Foundation, as well as partnering with industry to bring better treatments to patients. His NIH funded research has included work on both common (Parkinson’s & Alzheimer’s disease) and rare disorders (ATP1A3 post-infancy onset dystonia syndrome, or Rapid-onset Dystonia Parkinsonism). He has been performing Deep Brain Stimulation (DBS) surgeries since 2006 and has been part of pioneering efforts to improve targeting, increase the types of devices available to patients, and expand the number of diseases that treated by the technique. In addition to using DBS to treat Parkinson’s disease, Essential Tremor, and Dystonia, he has used it to treat patients with medication-refractory Tourette’s syndrome and Obsessive-Compulsive Disorder. Dr. Haq has also worked to advance the success of clinical trials, and shortly after being selected to the NIH Clinical Trial Methodology Course in 2017, served as the CoPI of the Wake Forest site for the NIH Network for Excellence in Neuroscience Clinical Trials (NeuroNext). Dr. Haq is a fellow of the American Academy of Neurology and was selected to its Emerging Leaders Program in 2015. He currently serves on the AAN’s Quality committee. Dr. Haq is also a member of the International Movement Disorders Society, Parkinson’s Study Group, and also serves on the Neurosciences Steering Board of the Epic electronic health record, working to define best EMR practices in the Neurosciences. |
Michael S. Okun received his M.D. with honors from the University of Florida. He was fellowship trained by Mahlon DeLong, Jerrold Vitek and Ray Watts at Emory University in Atlanta GA before moving to found the movement disorders program at the University of Florida. He is currently Chair of Neurology, Professor and Executive Director of the Norman Fixel Institute for Neurological Diseases at the University of Florida Health College of Medicine. The UF institute he co-founded with Kelly D. Foote, M.D. is unique in that it is comprised of over 100 interdisciplinary faculty members from diverse areas of campus, all of whom are dedicated to care, outreach, education and research. Dr. Okun was instrumental in the construction of a one-stop patient-centered clinical-research experience for national and international patients seeking care at the University of Florida. This change in care and research delivery has since been named the service and science hub model of care. The UF based center draws national and international visitors interested in deploying this innovative clinical-research model. Dr. Okun has served as the National Medical Director for the Parkinson’s Foundation since 2006 and as the Medical Advisor for Tyler’s Hope for a Dystonia Cure. He has been supported by grants from the National Institutes of Health, the Smallwood Foundation, the Tourette Association of America, the Parkinson Alliance, the Bachmann-Strauss Foundation, the Parkinson’s Foundation, and the Michael J. Fox Foundation. Dr. Okun has an active research career exploring non-motor basal ganglia brain features and currently holds two NIH R01 grants and several foundation grants exploring various aspects of deep brain stimulation and neuromodulation. Dr. Okun has been an integral part of some of the pioneering studies exploring the cognitive, behavioral, and mood effects of brain stimulation and since 2005 his laboratory has been working to uncover the electrical brain signals associated with human tic. He has also partnered with Dr. Ayse Gunduz and Kelly Foote to develop a first generation of closed loop adaptive deep brain stimulation
|
Dr. Jason Margolesky joined the Movement Disorders Division as an Assistant Professor of Clinical Neurology in 2017. He was born in Miami, Florida (a rare local). He received his undergraduate degree (BS) in Neuroscience and Behavioral Biology (with a minor in religion) at Emory University in Atlanta, Georgia. He then attended Georgetown University in Washington, DC where he earned a master’s degree in Physiology and Biophysics. He completed medical school (graduated in AOA honors society), residency training in neurology (served as administrative Chief Resident), and his Movement Disorders fellowship at the University of Miami Miller School of Medicine and Jackson Memorial Hospital in Miami, Florida. He is now Associate Program Director for the Neurology Resident Program and the University of Miami/Jackson Memorial Hospital.
Dr. Margolesky is board certified in Neurology by the American Board of Psychiatry and Neurology and is a member of the American Academy of Neurology, the Movement Disorders Society, and the MDSGene work group. He is primary or co-investigator in several research studies and clinical trials. He has received accolades for teaching including the Resident Teacher of the Year Award, the Faculty Award for Excellence in Teaching Medical Students, and the Chairman’s Award for Teaching Excellence. Clinical interests include childhood and young-onset onset movement disorders such as Wilson’s disease, Tourette syndrome and dystonia as well as Parkinson’s disease, atypical parkinsonism, essential tremor, Huntington disease, focal and generalized dystonia, tardive syndromes, ataxia, gait disorders, botulinum toxin injections and deep brain stimulation. Part of the interdisciplinary team recognized as Parkinson’s Disease, Tourette syndrome, and Wilson’s disease Centers of Excellence. |
James E. Galvin, M.D., M.P.H. is a Professor of Neurology and Psychiatry & Behavioral Sciences at the University of Miami Miller School of Medicine. He is the Founding Director of the Comprehensive Center for Brain Health, Director and Principal Investigator of the Lewy Body Dementia Research Center of Excellence, and Chief of Cognitive Neurology for Palm Beach and Broward County leading brain health and neurodegenerative disease research and clinical programs. Dr. Galvin has authored over 300 scientific publications and 3 textbooks on healthy brain aging, cognitive health, Alzheimer’s disease, Lewy Body dementia, and related disorders. Dr. Galvin has received over $100 Million in research funding from the National Institutes of Health, Alzheimer’s Association, Michael J Fox Foundation, American Federation for Aging Research, Lewy Body Dementia Association, Association for Frontotemporal Degeneration, Missouri, New York, and Florida Departments of Health, and numerous Private and Family Foundations.
The major focus of Dr. Galvin’s clinical and research career has been to improve the clinical care and quality of life for all older adults from diverse backgrounds and their family caregivers who are dealing with neurodegenerative disorders in order to initiate early intervention, alleviate psychosocial burden on the patient and family, reduce the impact of race, language, culture, and class on the delivery of health services, and improve health outcomes. His current research program focuses on four themes: (1) Developing and validating new clinical assessment scales to improve detection of cognitive impairment in multicultural community samples to improve health outcomes; (2) Studying the interaction between race, ethnicity, socioeconomic status, and multiple chronic conditions on the risk of cognitive impairment; (3) Characterizing the clinical, cognitive, behavioral, and biomarker features of neurodegenerative disorders; and (4) Creating novel precision-medicine based interventions based on individual phenotypic, biomarker, and genomic profiles aimed at ADRD risk reduction and dementia prevention. |
Dr. Emily Schultz is a Board Certified Neurologic Clinical Specialist in Physical Therapy with a passion for Neurologic Rehabilitation that began early. As a DPT student at the University of Evansville, Emily co-founded and was the first director of Acercise, the first DPT student run pro-bono group exercise program for individuals with neurologic conditions. Emily’s work in the clinic and as an advocate in the community has been the foundation of her early career.
Emily received her Doctor of Physical Therapy from the University of Evansville in 2016 before moving to Los Angeles to complete her postdoctoral training in the University of Southern California (USC) and Rancho Los Amigos Neurologic Rehabilitation Center Neurologic Physical Therapy Residency Program. As a resident of this prestigious program, Emily served as a clinician at Rancho Los Amigos Neurologic Rehabilitation Center, a Teacher’s Assistant for USC’s DPT Program, a multidisciplinary PT representative in numerous specialty neurology clinics at Keck Hospital of USC, and as a researcher collaborating with Dr. Rebecca Lewthwaite and Dr. Carolee Winstein. Emily graduated from this program in 2017 and moved to Miami, Florida where she currently resides. Emily presented her residency research titled “Relationships among Patient-reported and Performance-based Measures after Stroke” as a poster at CSM in 2018. She received her Board Certification as a Neurologic Clinical Specialist and became certified with use of Balance Wear: Balance Body Torso Weighting in 2018. Emily also was selected as a key speaker in the 25th Annual Brain Injury Symposium and presented her original work titled “Brain Injury Rehabilitation: Evidence Based Clinical Tools for Assessment and Treatment of Mild to Severe Brain Injury.” Emily’s passion for the academic and clinical world in neurologic PT continues to grow each year of her professional career. Emily currently works for the University of Miami in an outpatient neurologic PT setting. Emily is also a Core Faculty and a Mentor within the University of Miami and Jackson Rehabilitation Hospital Neurologic Residency Program. Emily serves as a Clinical Instructor for DPT students, a supervisor in the University of Miami’s Pro Bono student run clinic, and most recently reconnected to her LA ties working as a Teacher’s Assistant for USC’s DPT Summer Hybrid Immersion Program in the lab: Clinical Management of the Patient with Neurologic Dysfunction (PT 581L). In 2020, Emily took on an important role transitioning to provide physical therapy services via Telemedicine to individuals with neurologic conditions. Emily expanded her creativity of specialty practice to reach individuals and families impacted by neurologic diagnoses in their homes and continues to look for ways to build upon this practice with a special interest in creating opportunities for wellness programming. Outside of PT, Emily loves spending time with her family and friends, traveling to new countries, spending time outdoors, and watching and participating in sports. |
Dr. Laxman Bahroo, Associate Professor and Director of the Residency Program in the Department of Neurology at Georgetown University, presents an informational talk about APOKYN, a prescription-only medication that is used as needed to treat the symptoms of off episodes associated with advancing Parkinson's disease (PD). Dr. Bahroo is a Movement Disorders Specialist and manages an active clinic with interests in medical and surgical treatment.
|
Dr. Ihtsham Haq graduated from Columbia University with degrees in Bioengineering and in Philosophy. He completed his Neurology residency training at Georgetown University and his fellowship training at the University of Florida’s Movement Disorders & Neuro-restoration program at the Norman Fixel Institute for Neurological Diseases. He was previously Associate Professor at the Wake Forest School of Medicine in the Departments of Neurology and Neurosurgery before taking his current position as Division Chief at Miami in 2020.
His overall research interest has been in understanding and improving the care of patients with movement disorders, with a focus on technology and brain circuitry. He has been funded by the National Institute of Health, Parkinson’s Foundation, and Smallwood Foundation, as well as partnering with industry to bring better treatments to patients. His NIH funded research has included work on both common (Parkinson’s & Alzheimer’s disease) and rare disorders (ATP1A3 post-infancy onset dystonia syndrome, or Rapid-onset Dystonia Parkinsonism). He has been performing Deep Brain Stimulation (DBS) surgeries since 2006 and has been part of pioneering efforts to improve targeting, increase the types of devices available to patients, and expand the number of diseases that treated by the technique. In addition to using DBS to treat Parkinson’s disease, Essential Tremor, and Dystonia, he has used it to treat patients with medication-refractory Tourette’s syndrome and Obsessive-Compulsive Disorder. Dr. Haq has also worked to advance the success of clinical trials, and shortly after being selected to the NIH Clinical Trial Methodology Course in 2017, served as the CoPI of the Wake Forest site for the NIH Network for Excellence in Neuroscience Clinical Trials (NeuroNext). Dr. Haq is a fellow of the American Academy of Neurology and was selected to its Emerging Leaders Program in 2015. He currently serves on the AAN’s Quality committee. Dr. Haq is also a member of the International Movement Disorders Society, Parkinson’s Study Group, and also serves on the Neurosciences Steering Board of the Epic electronic health record, working to define best EMR practices in the Neurosciences. |
Henry Paul Moore, MD is a movement disorders specialist in neurology at the university of Miami medical center. Dr. Henry Moore joined the department as an assistant professor of clinical neurology. He earned his undergraduate and medical degree at Universidad peruana Cayetano Heredia – school of medicine, lima – Peru. He performed his neurology residency at Jackson memorial hospital / university of Miami – miller school of medicine. Then, he performed a 2-year movement disorders fellowship at Jackson memorial hospital / university of Miami – miller school of medicine.
|
Corneliu C. Luca, MD, PhD, is a board-certified movement disorders neurologist and clinician-researcher in the Department of Neurology at the University of Miami and Associate Professor of Neurology. Dr. Luca is also medical director of the Deep Brain Stimulation (DBS) clinical program at the University of Miami, and the Director of the Movement Disorders Fellowship. He served as principal investigator in more than 30 clinical trials for Parkinson’s disease and is an active member of Parkinson Study Group, a world-recognized clinical trial network for movement disorders. His research has received support from the National Institutes of Health, the American Academy of Neurology, and the Parkinson’s Foundation.
|
Dr. Arif I. Dalvi is a neurologist in Boynton Beach, Florida and is affiliated with Good Samaritan Medical Center-West Palm Beach. He received his medical degree from Rural Medical College Pravara Institute of Medical Sciences and has been in practice for more than 20 years.
|
|
|